Afatinib/osimertinibTreatment failure: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70778-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：28 / 28

相关论文

共 50 条

[31] LithiumRenal failure: 3 case reports
Reactions Weekly, 1998, 685 (1) : 9 - 10
[32] AntiretroviralsRespiratory failure: 3 case reports
Reactions Weekly, 2002, 887 (1) : 6 - 6
[33] Afatinib/gefitinib/osimertinibAcquired resistance: 4 case reports
Reactions Weekly, 2020, 1806 (1) : 21 - 21
[34] Afatinib/ramucirumabMultiple haemangioma and ileus: 2 case reports
Reactions Weekly, 2018, 1701 (1) : 16 - 16
[35] Afatinib/crizotinib/gefitinibDevelopment of resistance: 2 case reports
Reactions Weekly, 2018, 1712 (1) : 34 - 34
[36] Afatinib/erlotinib/gefitinibVarious toxicities: 22 case reports
Reactions Weekly, 2020, 1802 (1) : 16 - 16
[37] Afatinib/gefitinib/osimertinibVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1924 (1) : 27 - 27
[38] Afatinib/cetuximab/erlotinibAcneiform eruptions: 6 case reports
Reactions Weekly, 2021, 1871 (1) : 24 - 24
[39] Afatinib/cetuximab/erlotinibAcneiform eruption: 33 case reports
Reactions Weekly, 2019, 1739 (1) : 17 - 17
[40] Afatinib/crizotinib/erlotinibVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1796 (1) : 18 - 18

← 1 2 3 4 5 →